top of page

News: Nanobots developed as medical intervention

Researchers based out of ETH Zurich and the Helmholtz Institute Erlangen-Nuremberg for Renewable Energy have developed medical micro and Nano-sized robots. First presented in Nature Machine Intelligence in a paper by Daniel Ahmed et al., the robots were engineered with the intent of allowing doctors to access isolated regions of the human body without engaging in highly invasive procedures.

The robots could theoretically carry drugs or deliver other treatment through the body’s systems, such as through the bloodstream. The tiny robots have the capability to travel against the flow of a fluid, and this upstream motility is what makes it possible for them to deliver treatment to hard to reach areas.

The robots were inspired by naturally occurring micro swimmers, like bacteria or spermatozoa. They work by using acoustic-magnetic fields, which allows them to be easily controlled, non invasive, and to require less expensive components, as they do not require an on-board power supply. Essentially, they operate by the no-slip boundary conditions of a wall to autonomously move upstream.

This, along with the upstream motility, is what sets Ahmed and company’s research apart from previous Nano-bot attempts. The acoustic and magnetic fields used are safe to humans, and have been tested extensively in the clinical realm.

In the paper, Ahmed describes the research as, “A fundamental step towards the realization of micro-and Nano system navigation against the blood flow.”

The research has the potential to be a next-generation vehicle for targeted disease intervention. It follows a similar discovery by the Max Planck Institute for Intelligent Systems in May of 2020, which involved magnetically steering through the bloodstream micro-robots that resemble white blood cells.

Stay up to date on Clinical Trials

Citrus is a fully integrated recruitment and retention software that fits any clinical trial and simplifies the implementation of patient engagement in your clinical trial. Whether you are already working with CTMS systems or not, Citrus is the perfect add-on to make patient interaction effective.

Since 2015, our team has been hard at work raising awareness of clinical trials across the globe. A Forbes ‘30 Under 30’ company and a graduate of the renowned Techstar program in New York, Citruslabs is at the forefront of patient recruitment and retention technologies. With over 3 million patients now recorded on our databases, our patient recruitment dashboard is fast becoming the most efficient method of trial recruitment.

Now a #1 health app in 17 countries, our Mindmate app is helping to revolutionize the way we think about healthcare. Mindmate “[takes] senior care into the digital age” (Forbes, 2018) by providing people with cognitive decline the essential tools to help them rebuild and maintain strong mental health. Trusted by millions of users, our health community continues to grow as the content available expands to the needs of individuals today.

With more than 200 research sites now using the Citrus platform to screen thousands of patients every month, researchers are now well on their way to finding new treatments for hundreds of different health conditions - something that just would not be possible without a technological solution. Make sure that your clinical trial is in the lucky 12% and turn that luck into guaranteed results with Citrus.

Still a little unsure? Check out what our customers have to say about us here.

And If you’d like to know more about how Citruslabs can help you recruit more effectively, get in touch with our team here.


bottom of page